Ministry of Health and Welfare and HIRA Release 2024 Expenditure Reports and Survey Results

The total economic benefits provided by pharmaceutical and medical device sales companies to doctors—including payment discounts and samples—exceeded 840 billion won in a single year.


"From Discounts to Samples"... Promotional Expenses by 4,700 Pharmaceutical and Medical Device Companies Exceed 840 Billion Won View original image

The Ministry of Health and Welfare announced on March 13 that, together with the Health Insurance Review and Assessment Service, it will release expenditure reports detailing the economic benefits provided in 2024 by pharmaceutical and medical device suppliers and promotional sales representatives to healthcare professionals and others.


The expenditure report system was introduced in 2018 to enhance transparency in pharmaceutical and medical device transactions and to promote self-regulation within the industry. This most recent survey marks the third implementation since the system's introduction.


A total of 28,118 companies submitted expenditure reports for the survey, which was overseen by the Health Insurance Review and Assessment Service. The number of companies submitting reports increased by 29.0% compared to the second survey conducted in 2024.


The survey found that 4,778 companies provided economic benefits to healthcare professionals, accounting for 17.0% of all reporting companies. The total value of economic benefits provided was 842.7 billion won, encompassing 23.26 million products. This represents a slight increase compared to the second survey, which reported 818.2 billion won and 21.19 million products.


For pharmaceuticals, the most common forms of economic benefit were payment discounts (55.1%) and product briefings (42.3%). Payment discounts refer to reductions offered to hospitals, clinics, or pharmacies when pharmaceutical bills are paid early.


For medical devices, the majority of economic benefits were provided in the form of samples (57.8%), followed by product briefings (24.1%), performance verification of medical devices (20.8%), and academic conferences (20.1%).


Company-specific expenditure reports will be made available for the next five years through the expenditure report management system on the Health Insurance Review and Assessment Service’s website, starting today.



Kwak Soonheon, Director General for Healthcare Policy at the Ministry of Health and Welfare, stated, "The disclosure of expenditure reports is more than just an information release; it is a system designed to enhance trust across the entire pharmaceutical and medical device distribution sector. Active cooperation from the industry is crucial for stable operation," adding, "The government will also continue its efforts, together with the industry, to establish a transparent and sound distribution order for pharmaceuticals and medical devices."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing